Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:e71
doi: 10.1161/01.RES.0000126418.31311.F8
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skowasch, D.
Right arrow Articles by Bauriedel, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skowasch, D.
Right arrow Articles by Bauriedel, G.
(Circulation Research. 2004;94:e71.)
© 2004 American Heart Association, Inc.


Letter to the Editor

Bone Marrow–Derived Cells and Vascular Growth

Dirk Skowasch, Alexander Jabs, Berndt Lüderitz, Gerhard Bauriedel

Department of Cardiology, University of Bonn, Bonn, Germany, Gerhard.Bauriedel@ukb.uni-bonn.de


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

We read with great interest the study by Ziegelhoeffer et al,1 who tested whether circulating bone marrow–derived cells incorporate into collateral arteries after femoral artery ligation. Although the investigators did not find any incorporation of bone marrow–derived cells in the endothelium and tunica media of growing vessels, they observed accumulations of bone marrow–derived cells in areas of collateral artery growth and capillary growth and identified these cells as fibroblasts, pericytes, and primarily leukocytes. These exciting data add another piece of evidence to the concept that apparently not mural, tissue-resident cells but other cell types play a more central role in vascular repair.

Given the diversity of blood leukocyte populations, the exact identity of these cells deserves careful consideration. In this context, we recently identified dendritic cells as a novel neointimal cell type and demonstrated their maximal frequency during early neointima formation after rat carotid balloon injury.2 In another study, we also showed bone marrow– and neural crest–derived cells within human in-stent restenosis atherectomy samples.3 Herein, dendritic cells constituted the major mononuclear lesional cell type, whereas monocytes/macrophages were confined to areas adjacent to stent struts.3 It is tempting to speculate that dendritic cells may have contributed to the bone marrow–derived perivascular leukocyte populations described by Ziegelhoeffer et al.1 Because most dendritic cells are thought to originate from hematopoietic stem cells and to share initial differentiation steps with monocytes,4 we also would like to suggest that further studies on vascular repair should evaluate the presence of specific subpopulations of . . . [Full Text of this Article]